Attached herewith Annual report of Financial Year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archit Organosys Limited has submitted its Annual Report for Financial Year 2024-25 to BSE, along with the notice for its 32nd Annual General Meeting scheduled for Monday, 29 September 2025 at 11:00 AM, to be held via video conferencing. The Board has recommended a dividend of Rs. 0.50 (5%) per equity share on a face value of Rs. 10, with the record date set as 22 September 2025. Shareholders will also vote on re-appointments of Shri Kandarp K. Amin (Chairman & WTD), Smt. Archana K. Amin (WTD), Shri Archit K. Amin (WTD), and Shri Nikul J. Patel (Independent Director), along with approval for a related-party loan transaction of up to Rs. 50 crore to Archit Life Science Limited for FY 2025-26 and FY 2026-27. New Secretarial Auditors, M/s. Ankit Sethi & Associates, have been proposed for a five-year term from FY 2025-26 to FY 2029-30.
For retail investors, this is a routine regulatory filing that confirms a small dividend (Rs. 0.50/share), continued family-led management with promoter re-appointments, and a notable related-party loan cap of Rs. 50 crore to a group entity. The AGM items, if approved, will keep existing leadership in place and formalise the related-party funding arrangement, which investors should review in the full annual report.